Mycoplasma Pneumoniae Clinical Trial
Official title:
A Double-Blind, Randomized Placebo-Controlled Trial of Doxycycline for Chemoprophylaxis in the Setting of an Outbreak of Mycoplasma Pneumoniae
This study was designed to determine whether taking daily doxycycline during an outbreak of Mycoplasma pneumoniae could prevent a person from getting infected and interrupt ongoing disease transmission during an outbreak. Doxycycline is a treatment for Mycoplasma pneumoniae, but it is not certain that the drug could prevent disease if used prophylactically.
Status | Completed |
Enrollment | 0 |
Est. completion date | April 1994 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Working at hospital facility where outbreak of Mycoplasma pneumoniae occured Exclusion Criteria: - Pregnant, on antiseizure medications, allergic to macrolide antibiotics |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Centers for Disease Control and Prevention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06325293 -
A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study
|
N/A | |
Completed |
NCT02511262 -
Detection of Mycoplasma Pneumoniae
|
N/A |